Morgan Stanley Grows More Bullish on JNJ Wednesday, October 20, 11:41 AM ET, by Market News Video Staff This morning, Morgan Stanley raised its EPS estimates on shares of Johnson & Johnson (JNJ) ...
GENZ Searches for “White Knight” to Trump Sanofi Monday, November 15, 12:13 PM ET, by Market News Video Staff Genzyme (GENZ) shares are trading higher today on media reports that it is trying to ...
JNJ Ordered to Pay $130M to Swiss Basilea Monday, November 29, 12:44 PM ET, by Market News Video Staff Johnson & Johnson (JNJ) shares are falling today after it was ordered to pay $130 ...
NKBP Crosses Above Key Moving Average Level Monday, May 2, 1:02 PM ET, by Market News Video Staff In trading on Monday, shares of China Nuokang Bio-Pharmaceutical, Inc. (NKBP) crossed above their 200 ...
AGN Ex-Dividend Reminder - 5/18/11 Monday, May 16, 10:26 AM ET, by Market News Video Staff On 5/18/11, Allergan, Inc (AGN) will trade ex-dividend, for its quarterly dividend of $0.05, payable ...
In trading on Thursday, shares of China Nuokang Bio-Pharmaceutical, Inc. (NASDAQ:NKBP) crossed above their 200 day moving average of $4.21, changing hands as high as $4.44 per share. China Nuokang Bio-Pharmaceutical, Inc. shares are currently trading up about 8.8% on the day. The chart below shows the one year performance of NKBP shares, versus its 200 day moving average:
Looking at the chart above, NKBP's low point in its 52 week range is $3.25 per share, with $6.65 as the 52 week high point — that compares with a last trade of $4.34.
NKBP operates in the Drugs & Pharmaceuticals sector, among companies like Sanofi (NYSE:SNY) which is off about 0.3% today, and Abbott Laboratories (NYSE:ABT) trading lower by about 1.4%. Below is a three month price history chart comparing the stock performance of NKBP, versus SNY and ABT.
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud:AbbottAboveBelowChinaInvestmentMovingNKBPNYSENuokangPharmaceuticalPharmaceuticalsPortfolioaboutaboveallowsamongassetaveragebondschartclassescompaniescompletecompletelycountriescurrentlydesignedgrowthhandshighhistoryleadsmovingoperatesperformancepointportfoliopriceprogramrangeraquosharesharesshortstockstermstradingversusweekwith
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Now Playing:
Learn About The 200 DMA
Start slideshow:
Analyst Moves: SBUX, NDSN
Daily Dividend Report: KFT, MRK, C, WRB, DCI
Analyst Moves: SBUX, NDSN
Weekly Market Wrap: May 11, 2012
Week Ahead Market Report: May 14, 2012
Weekly Market Wrap: May 18, 2012
